Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP6 | P55212 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | HCAR3 | P49019 | 12/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | APEX1 | P27695 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30810715 | 1.00 | CASP6 (0.72) | CASP6TSHRLMNAHCAR3POLB | |
| SCHEMBL842661 | 1.00 | CASP6 (0.72) | CASP6TSHRLMNAHCAR3POLB | |
| SCHEMBL11649278 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3POLB | |
| Ammonia Solution, Strong SCHEMBL32680170 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3POLB | |
| Terephthalic Acid SCHEMBL15808957 | 0.98 | CASP6 (0.70) | CASP6TSHRLMNAHCAR3POLB | |
| SCHEMBL15808913 | 0.92 | TSHR (0.71) | CASP6TSHRLMNAHCAR3POLB | |
| SCHEMBL1633750 | 0.87 | CASP6 (0.66) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL13816483 | 0.87 | CASP6 (0.66) | CASP6TSHRLMNAHCAR3APEX1 | |
| SCHEMBL2433562 | 0.87 | CASP6 (0.66) | CASP6TSHRLMNAHCAR3POLB | |
| SCHEMBL8787371 | 0.87 | PARP1 (0.63) | CASP6TSHRLMNAHCAR3POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1952 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118079944-B | Porous chromium-based composite denitration catalyst and preparation method and application thereof | 山东大学 | 2026-05-22 | — | — | CN | claimed |
| CN-117599848-B | High-stability MOFs-based non-noble metal monoatomic catalyst and preparation method and application thereof | 中国科学院大连化学物理研究所 | 2026-05-19 | — | — | CN | claimed |
| WO-2026100858-A1 | POLYMER FILM COMPRISING POLYMER NANOFIBERS LOADED WITH METAL-ORGANIC FRAMEWORKS, TRIBOELECTRIC-BASED NANOGENERATOR COMPRISING SAME, AND METHOD FOR MANUFACTURING POLYMER NANOFIBERS LOADED WITH METAL-ORGANIC FRAMEWORKS | 서울대학교산학협력단 | 2026-05-15 | — | — | WO | claimed |
| EP-3948264-B1 | NON-BLEACHING COLORIMETRIC AND FLUOROMETRIC ANALYTE DETECTION BY DEGRADATION OF SOLIDS | HACH CO (US) | 2026-05-06 | — | — | EP | claimed |
| US-20260066298-A1 | METHOD FOR MANUFACTURING METAL-ORGANIC FRAMEWORK, METAL-ORGANIC FRAMEWORK, AND ALL-SOLID-STATE BATTERY ANODE INCLUDING THE SAME | HYUNDAI MOTOR CO LTD (KR) | 2026-03-05 | — | — | US | claimed |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| EP-4651988-A1 | METHODS OF MAKING METAL-ORGANIC FRAMEWORKS WITH PRE-LIGANDS | ExxonMobil Technology and Engineering Company (US) | 2025-11-26 | — | — | EP | claimed |
| US-20250354659-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | NUOVO PIGNONE TECNOLOGIE – S R L (IT) | 2025-11-20 | — | — | US | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| US-20020019430-A1 | Nervous system and psychological disorders | EISAI INC. | 2002-02-14 | — | — | US | claimed |
| US-20020013295-A1 | Naaladase inhibitors for treating amyotrophic lateral sclerosis | GUILFORD PHARMACEUTICALS INC., A DELAWARE CORPORATION | 2002-01-31 | — | — | US | claimed |
| WO-2001092273-A2 | BENZENEDICARBOXYLIC ACID DERIVATIVES | GUILFORD PHARMACEUTICALS INC. (US) | 2001-12-06 | — | — | WO | claimed |
| WO-2001092274-A2 | NAALADASE INHIBITORS FOR TREATING RETINAL DISORDERS AND GLAUCOMA | GUILFORD PHARMACEUTICALS INC. (US) | 2001-12-06 | — | — | WO | claimed |
| WO-2001091738-A2 | NAALADASE INHIBITORS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | GUILFORD PHARMACEUTICALS INC. (US) | 2001-12-06 | — | — | WO | claimed |
| WO-1999066333-A1 | NEUTRAL ENHANCEMENT OF LANTHANIDES FOR TIME RESOLVED FLUORESCENCE | NEN LIFE SCIENCE PRODUCTS, INC. (US) | 1999-12-23 | — | — | WO | claimed |
| US-4906771-A | Process for catalytic oxidation of ortho-nitroaromatic compounds to ortho-nitroaromatic acids | AMOCO CORPORATION (US) | 1990-03-06 | — | — | US | claimed |
| US-4551549-A | AMMONOLYSIS OF DIALKYL NITROTEREPHTHALATES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-11-05 | — | — | US | claimed |
| US-4507491-A | Process for preparing 1-nitrobenzene-2-alkyloxycarbonyl-5-carboxylic acids | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-03-26 | — | — | US | claimed |
| EP-0083417-B1 | PROCESS FOR MAKING 2-CARBALKOXY-5-CARBOXYNITROBENZENES | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-09-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013295-A1 | Naaladase inhibitors for treating amyotrophic lateral sclerosis | SMN1; SMN2, GAA, NAALAD2 | CASP6 2689/4885TSHR 4825/4885LMNA 1107/4885 |
| US-20260066298-A1 | METHOD FOR MANUFACTURING METAL-ORGANIC FRAMEWORK, METAL-ORGANIC FRAMEWORK, AND ALL-SOLID-STATE BATTERY ANODE INCLUDING THE SAME | TWF2, PUF60, U2AF1 | CASP6 962/4885TSHR 1506/4885LMNA 1820/4885 |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | CASP6 2171/4885TSHR 1726/4885LMNA 2914/4885 |
| US-20020019430-A1 | Nervous system and psychological disorders | GLUL, DDC, DNPEP | CASP6 855/4885TSHR 4664/4885LMNA 3619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.